The invention relates to a preparation method and application of an osteoporotegerin-heat-shock
protein 65-fused
protein, belonging to the new technical field of
biomedicine. The invention provides an osteoporotegerin-heat-shock
protein 65 (OPG-HSP 65)-fused recombinant protein medicament. Aiming at the most important
pathological feature of
rheumatoid arthritis (RA) that articular
synovitis is accompanied with the destroy of cartilages and bones, the medicament can be combined with a
receptor activator of
nuclear factor kappa B ligand (
RANKL) expressed by cells comprising osteoblasts and the like through using osteoporotegerin (OPG) as a
decoy receptor to block the combination of the
RANKL and a RANK (
Receptor Activator of NF-kB) expressed by osteoclasts, thereby inhibiting the bone absorption that the osteoclasts participate; and the medicament inhibits articular inflammations by utilizing the protective polypeptide segment of the heat-shock protein (HSP). The invention comprises
a DNA (Deoxyribonucleic Acid) sequence for encoding recombinant protein, a method for generating the recombinant protein through a recomposition technique, the biologic activity of the recombinant protein and the like.